Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/1996
08/21/1996EP0474787B1 A process for treating infertility and an agent for use in the process
08/21/1996CN1129219A Pharmaceutical compounds
08/20/1996US5547945 Administering polysaccharide which is extracted from tanjin plant with water or aqueous solvent
08/18/1996CA2168303A1 Azepinone compounds useful in the inhibition of ace and nep
08/16/1996CA2169433A1 Adhesion receptor antagonists
08/15/1996WO1996011685A3 Use of indole derivatives for the treatment of various diseases
08/14/1996EP0725819A1 A method for detection of alterations in the dna mismatch repair pathway
08/14/1996EP0725798A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas
08/14/1996EP0725796A1 Growth differentiation factor-10
08/14/1996EP0725782A1 Novel a 1 adenosine receptor agonists and antiagonists
08/14/1996EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
08/14/1996CN1128950A Method for modulating human sexual response
08/14/1996CN1128752A Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines, prepn. method and usage thereof
08/13/1996US5545838 Hypotensive agents
08/13/1996US5545738 Useful for production of antihypertensive agents and dysurea curing agents
08/13/1996US5545645 Heterocyclic derivatives in the treatment of ischaemia and related diseases
08/13/1996US5545408 Containing lutenizing hormone releasing hormone agonist
08/08/1996WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/08/1996WO1996023503A1 Progesterone antagonists useful for preparing medicaments for treating dysfunctional uterine bleeding
08/08/1996WO1996023492A1 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin
08/08/1996WO1996023490A1 Formulations and methods for reducing skin irritation
08/08/1996CA2212127A1 Formulations and methods for reducing skin irritation
08/07/1996EP0725074A2 Compounds suitable for use as intermediates in the preparation of Androst-3,5-dien-3-carboxy derivatives
08/07/1996EP0724440A1 Di- and tetra-hydrobenzo f]quinolin-3-ones
08/07/1996CN1128536A Benzopyrans and pharmaceutical compositions containing them
08/07/1996CN1128262A Substituted biphenyl isoxazole sulfonamides
08/07/1996CN1128260A New piperidine compounds, process for their preparation and the pharmaceutical compositions which contain them
08/07/1996CN1128151A Pills for prostata disease
08/06/1996US5543420 Aldose reductase inhibitors; antidiabetic agents; prevention of accumulation of sorbitol and galactitol in mammalian tissue
08/01/1996WO1996022992A1 Tricyclic substituted hexahydrobenz[e]isoindole alpha-1 adrenergic antagonists
08/01/1996WO1996022991A1 Bicyclic substituted hexahydrobenz[e]isoindole alpha-1- adrenergic antagonists
08/01/1996CA2211212A1 Tricyclic substituted hexahydrobenz¬e|isoindole alpha-1 adrenergic antagonists
08/01/1996CA2210966A1 Bicyclic substituted hexahydrobenz[e]isoindole alpha-1- adrenergic antagonists
07/1996
07/31/1996EP0723959A1 Heterocyclic compounds as tachykinin receptor antagonists, process for their preparation and pharmaceuticals containing them
07/31/1996EP0723956A1 Basically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics as well as medicaments containing them
07/31/1996EP0723779A1 Medicament for treatment of hypothalamic amenorrhea
07/31/1996EP0723595A1 A novel nuclear mitotic phosphoprotein: mitosin
07/31/1996EP0723457A1 Transferrin compositions to alleviate the side effects of cytotoxic drugs
07/31/1996EP0723453A1 Method of treating reproductive disorders
07/31/1996EP0723450A1 Inhibition of urinary calculi growth
07/31/1996EP0723447A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
07/31/1996CN1127749A Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
07/31/1996CA2168315A1 Basically-substituted benzoylguanidines, a process for preparing them, their use as a medicament or diagnostic agent, and a medicament containing them
07/31/1996CA2167999A1 Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
07/30/1996US5541229 Benzimidazoles and medicaments containing these compounds
07/30/1996US5541228 Melatonergic agents
07/30/1996US5541219 Antiinflammatory agents; aids
07/30/1996US5541190 Treating benign prostatic hyperplasia, male pattern baldness, prostatic cancer, androgenic alopecia
07/30/1996CA2043440C Method of treating impotence
07/25/1996WO1996022295A1 Tricyclic benzazepine vasopressin antagonists
07/25/1996WO1996022294A1 Bicyclic benzazepine derivatives as vasopressin antagonists
07/25/1996WO1996022292A1 Tricyclic vasopressin antagonists
07/25/1996WO1996022290A1 Compounds having effects on serotonin-related systems
07/25/1996WO1996022282A1 Tricyclic benzazepine vasopressin antagonists
07/25/1996WO1996022095A2 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
07/25/1996WO1996022021A1 Protein hydroxylation inhibitors for fibroproliferative disorders
07/25/1996WO1996008228A3 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
07/25/1996CA2210885A1 Protein hydroxylation inhibitors for fibroproliferative disorders
07/25/1996CA2210688A1 Tricyclic benzazepine vasopressin antagonists
07/25/1996CA2210632A1 Tricyclic benzazepine vasopressin antagonists
07/25/1996CA2210571A1 Bicyclic benzazepine derivatives as vasopressin antagonists
07/25/1996CA2210220A1 Compounds having effects on serotonin-related systems
07/24/1996EP0722944A1 2-9-Disubstituted Purin-6-ones
07/24/1996EP0722943A1 9-Substituted 2-(2-n-alkoxyphenyl)-purin-6-ones
07/24/1996EP0722941A2 Compounds having effects on serotonin-related systems
07/24/1996EP0722937A1 2,8-Disubstituted quinazolinone
07/24/1996EP0722728A1 Benzofuran derivatives for inhibiting endometriosis
07/24/1996EP0722727A1 Benzofuran derivatives for inhibiting uterine fibroid disease
07/24/1996EP0714300A4 Methods for modulating the human sexual response
07/24/1996CN1127473A Combination of a progestational agent and a nitric oxide synthase substrate and/or donor for the treatment of preeclampsia and preterm labor
07/24/1996CN1127252A Branched-amino-sbustituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
07/23/1996CA2001996C Method of treatment for interstitial cystitis
07/21/1996CA2167472A1 Methods of inhibiting endometriosis
07/21/1996CA2167460A1 Methods for inhibiting uterine fibroid disease
07/20/1996CA2167353A1 2,9-disubstituted purin-6-ones
07/20/1996CA2167349A1 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones
07/20/1996CA2167345A1 2,8-disubstituted quinazolinones
07/18/1996WO1996021463A2 New applications of lysozyme dimer
07/18/1996WO1996008569A3 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
07/18/1996CA2210091A1 New applications of lysozyme dimer
07/17/1996EP0721349A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin
07/17/1996EP0721348A1 Monoglyceride/lactate ester permeation enhancer
07/17/1996EP0721345A1 Prostatic cancer vaccine
07/17/1996CN1126999A Peptides exhibiting oxytocin antagonistic activity
07/16/1996US5536714 Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses
07/11/1996WO1996020704A1 Treating disorders characterised by excessive cell proliferation with sclareolide
07/11/1996CA2209276A1 Treating disorders characterised by excessive cell proliferation with sclareolide
07/10/1996EP0720477A1 Method and compositions for maintaining glomerular filtration rate while inhibition extracellular matrix accumulation
07/10/1996CN1126466A Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
07/10/1996CN1126439A Compositions for nasal administration of desmopressin
07/10/1996CN1126201A Fullfluoralkyl-substituted bezoylguanidine, preparation, parmaceuticle use of same and pharmaceutical containing same
07/09/1996CA2073601C Pharmaceutical compositions containing rifaximin for treatment of vaginal infections
07/04/1996WO1996020207A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
07/04/1996WO1996020194A1 Novel quinuclidine derivatives and medicinal composition thereof
07/04/1996WO1996020013A1 Improvements in or relating to endometrial function
07/04/1996WO1996019997A1 Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception
07/04/1996CA2208706A1 Mutants of the rb and p53 genes and uses thereof
07/04/1996CA2208446A1 Improvements in or relating to endometrial function
07/04/1996CA2208321A1 Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
07/03/1996EP0719770A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition
1 ... 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 ... 562